img

Global Inactivated Polio Virus Vaccine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Inactivated Polio Virus Vaccine Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Inactivated Polio Virus Vaccine Market
Global Inactivated Polio Virus Vaccine market is expected to reach to US$ 715.8 million in 2024, with a positive growth of %, compared with US$ 688.5 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Inactivated Polio Virus Vaccine industry is evaluated to reach US$ 926.8 million in 2029. The CAGR will be 4.4% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Inactivated Polio Virus Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Inactivated Polio Virus Vaccine market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Segment by Type
Type I
Type II
Type III

Segment by Application


Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Inactivated Polio Virus Vaccine introduction, etc. Inactivated Polio Virus Vaccine Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Inactivated Polio Virus Vaccine
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Market by Application
1.3.1 Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inactivated Polio Virus Vaccine Market Perspective (2018-2029)
2.2 Global Inactivated Polio Virus Vaccine Growth Trends by Region
2.2.1 Inactivated Polio Virus Vaccine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Inactivated Polio Virus Vaccine Historic Market Size by Region (2018-2024)
2.2.3 Inactivated Polio Virus Vaccine Forecasted Market Size by Region (2024-2029)
2.3 Inactivated Polio Virus Vaccine Market Dynamics
2.3.1 Inactivated Polio Virus Vaccine Industry Trends
2.3.2 Inactivated Polio Virus Vaccine Market Drivers
2.3.3 Inactivated Polio Virus Vaccine Market Challenges
2.3.4 Inactivated Polio Virus Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Inactivated Polio Virus Vaccine by Players
3.1.1 Global Inactivated Polio Virus Vaccine Revenue by Players (2018-2024)
3.1.2 Global Inactivated Polio Virus Vaccine Revenue Market Share by Players (2018-2024)
3.2 Global Inactivated Polio Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Inactivated Polio Virus Vaccine, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Inactivated Polio Virus Vaccine Market Concentration Ratio
3.4.1 Global Inactivated Polio Virus Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inactivated Polio Virus Vaccine Revenue in 2022
3.5 Global Key Players of Inactivated Polio Virus Vaccine Head office and Area Served
3.6 Global Key Players of Inactivated Polio Virus Vaccine, Product and Application
3.7 Global Key Players of Inactivated Polio Virus Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Inactivated Polio Virus Vaccine Breakdown Data by Type
4.1 Global Inactivated Polio Virus Vaccine Historic Market Size by Type (2018-2024)
4.2 Global Inactivated Polio Virus Vaccine Forecasted Market Size by Type (2024-2029)
5 Inactivated Polio Virus Vaccine Breakdown Data by Application
5.1 Global Inactivated Polio Virus Vaccine Historic Market Size by Application (2018-2024)
5.2 Global Inactivated Polio Virus Vaccine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Inactivated Polio Virus Vaccine Market Size (2018-2029)
6.2 North America Inactivated Polio Virus Vaccine Market Size by Type
6.2.1 North America Inactivated Polio Virus Vaccine Market Size by Type (2018-2024)
6.2.2 North America Inactivated Polio Virus Vaccine Market Size by Type (2024-2029)
6.2.3 North America Inactivated Polio Virus Vaccine Market Share by Type (2018-2029)
6.3 North America Inactivated Polio Virus Vaccine Market Size by Application
6.3.1 North America Inactivated Polio Virus Vaccine Market Size by Application (2018-2024)
6.3.2 North America Inactivated Polio Virus Vaccine Market Size by Application (2024-2029)
6.3.3 North America Inactivated Polio Virus Vaccine Market Share by Application (2018-2029)
6.4 North America Inactivated Polio Virus Vaccine Market Size by Country
6.4.1 North America Inactivated Polio Virus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Inactivated Polio Virus Vaccine Market Size by Country (2018-2024)
6.4.3 North America Inactivated Polio Virus Vaccine Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Inactivated Polio Virus Vaccine Market Size (2018-2029)
7.2 Europe Inactivated Polio Virus Vaccine Market Size by Type
7.2.1 Europe Inactivated Polio Virus Vaccine Market Size by Type (2018-2024)
7.2.2 Europe Inactivated Polio Virus Vaccine Market Size by Type (2024-2029)
7.2.3 Europe Inactivated Polio Virus Vaccine Market Share by Type (2018-2029)
7.3 Europe Inactivated Polio Virus Vaccine Market Size by Application
7.3.1 Europe Inactivated Polio Virus Vaccine Market Size by Application (2018-2024)
7.3.2 Europe Inactivated Polio Virus Vaccine Market Size by Application (2024-2029)
7.3.3 Europe Inactivated Polio Virus Vaccine Market Share by Application (2018-2029)
7.4 Europe Inactivated Polio Virus Vaccine Market Size by Country
7.4.1 Europe Inactivated Polio Virus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Inactivated Polio Virus Vaccine Market Size by Country (2018-2024)
7.4.3 Europe Inactivated Polio Virus Vaccine Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Inactivated Polio Virus Vaccine Market Size (2018-2029)
8.2 China Inactivated Polio Virus Vaccine Market Size by Type
8.2.1 China Inactivated Polio Virus Vaccine Market Size by Type (2018-2024)
8.2.2 China Inactivated Polio Virus Vaccine Market Size by Type (2024-2029)
8.2.3 China Inactivated Polio Virus Vaccine Market Share by Type (2018-2029)
8.3 China Inactivated Polio Virus Vaccine Market Size by Application
8.3.1 China Inactivated Polio Virus Vaccine Market Size by Application (2018-2024)
8.3.2 China Inactivated Polio Virus Vaccine Market Size by Application (2024-2029)
8.3.3 China Inactivated Polio Virus Vaccine Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Inactivated Polio Virus Vaccine Market Size (2018-2029)
9.2 Asia Inactivated Polio Virus Vaccine Market Size by Type
9.2.1 Asia Inactivated Polio Virus Vaccine Market Size by Type (2018-2024)
9.2.2 Asia Inactivated Polio Virus Vaccine Market Size by Type (2024-2029)
9.2.3 Asia Inactivated Polio Virus Vaccine Market Share by Type (2018-2029)
9.3 Asia Inactivated Polio Virus Vaccine Market Size by Application
9.3.1 Asia Inactivated Polio Virus Vaccine Market Size by Application (2018-2024)
9.3.2 Asia Inactivated Polio Virus Vaccine Market Size by Application (2024-2029)
9.3.3 Asia Inactivated Polio Virus Vaccine Market Share by Application (2018-2029)
9.4 Asia Inactivated Polio Virus Vaccine Market Size by Region
9.4.1 Asia Inactivated Polio Virus Vaccine Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Inactivated Polio Virus Vaccine Market Size by Region (2018-2024)
9.4.3 Asia Inactivated Polio Virus Vaccine Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Inactivated Polio Virus Vaccine Introduction
11.1.4 Sanofi Revenue in Inactivated Polio Virus Vaccine Business (2018-2024)
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Inactivated Polio Virus Vaccine Introduction
11.2.4 GSK Revenue in Inactivated Polio Virus Vaccine Business (2018-2024)
11.2.5 GSK Recent Developments
11.3 Serum Institute (Bilthoven Biologicals)
11.3.1 Serum Institute (Bilthoven Biologicals) Company Details
11.3.2 Serum Institute (Bilthoven Biologicals) Business Overview
11.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Introduction
11.3.4 Serum Institute (Bilthoven Biologicals) Revenue in Inactivated Polio Virus Vaccine Business (2018-2024)
11.3.5 Serum Institute (Bilthoven Biologicals) Recent Developments
11.4 IMBCA
11.4.1 IMBCA Company Details
11.4.2 IMBCA Business Overview
11.4.3 IMBCA Inactivated Polio Virus Vaccine Introduction
11.4.4 IMBCA Revenue in Inactivated Polio Virus Vaccine Business (2018-2024)
11.4.5 IMBCA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Type I
Table 3. Key Players of Type II
Table 4. Key Players of Type III
Table 5. Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Inactivated Polio Virus Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Inactivated Polio Virus Vaccine Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Inactivated Polio Virus Vaccine Market Share by Region (2018-2024)
Table 9. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Inactivated Polio Virus Vaccine Market Share by Region (2024-2029)
Table 11. Inactivated Polio Virus Vaccine Market Trends
Table 12. Inactivated Polio Virus Vaccine Market Drivers
Table 13. Inactivated Polio Virus Vaccine Market Challenges
Table 14. Inactivated Polio Virus Vaccine Market Restraints
Table 15. Global Inactivated Polio Virus Vaccine Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Inactivated Polio Virus Vaccine Revenue Share by Players (2018-2024)
Table 17. Global Top Inactivated Polio Virus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Virus Vaccine as of 2022)
Table 18. Global Inactivated Polio Virus Vaccine Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Inactivated Polio Virus Vaccine Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Inactivated Polio Virus Vaccine, Headquarters and Area Served
Table 21. Global Key Players of Inactivated Polio Virus Vaccine, Product and Application
Table 22. Global Key Players of Inactivated Polio Virus Vaccine, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Inactivated Polio Virus Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Inactivated Polio Virus Vaccine Revenue Market Share by Type (2018-2024)
Table 26. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Inactivated Polio Virus Vaccine Revenue Market Share by Type (2024-2029)
Table 28. Global Inactivated Polio Virus Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Inactivated Polio Virus Vaccine Revenue Share by Application (2018-2024)
Table 30. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Inactivated Polio Virus Vaccine Revenue Share by Application (2024-2029)
Table 32. North America Inactivated Polio Virus Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Inactivated Polio Virus Vaccine Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Inactivated Polio Virus Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Inactivated Polio Virus Vaccine Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Inactivated Polio Virus Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Inactivated Polio Virus Vaccine Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Inactivated Polio Virus Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Inactivated Polio Virus Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Inactivated Polio Virus Vaccine Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Inactivated Polio Virus Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Inactivated Polio Virus Vaccine Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Inactivated Polio Virus Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Inactivated Polio Virus Vaccine Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Inactivated Polio Virus Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Inactivated Polio Virus Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Inactivated Polio Virus Vaccine Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Inactivated Polio Virus Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Inactivated Polio Virus Vaccine Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Inactivated Polio Virus Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Inactivated Polio Virus Vaccine Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Inactivated Polio Virus Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Inactivated Polio Virus Vaccine Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Inactivated Polio Virus Vaccine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Inactivated Polio Virus Vaccine Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Inactivated Polio Virus Vaccine Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi Inactivated Polio Virus Vaccine Product
Table 67. Sanofi Revenue in Inactivated Polio Virus Vaccine Business (2018-2024) & (US$ Million)
Table 68. Sanofi Recent Developments
Table 69. GSK Company Details
Table 70. GSK Business Overview
Table 71. GSK Inactivated Polio Virus Vaccine Product
Table 72. GSK Revenue in Inactivated Polio Virus Vaccine Business (2018-2024) & (US$ Million)
Table 73. GSK Recent Developments
Table 74. Serum Institute (Bilthoven Biologicals) Company Details
Table 75. Serum Institute (Bilthoven Biologicals) Business Overview
Table 76. Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Product
Table 77. Serum Institute (Bilthoven Biologicals) Revenue in Inactivated Polio Virus Vaccine Business (2018-2024) & (US$ Million)
Table 78. Serum Institute (Bilthoven Biologicals) Recent Developments
Table 79. IMBCA Company Details
Table 80. IMBCA Business Overview
Table 81. IMBCA Inactivated Polio Virus Vaccine Product
Table 82. IMBCA Revenue in Inactivated Polio Virus Vaccine Business (2018-2024) & (US$ Million)
Table 83. IMBCA Recent Developments
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Inactivated Polio Virus Vaccine Market Share by Type: 2022 VS 2029
Figure 3. Type I Features
Figure 4. Type II Features
Figure 5. Type III Features
Figure 6. Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Inactivated Polio Virus Vaccine Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Inactivated Polio Virus Vaccine Report Years Considered
Figure 11. Global Inactivated Polio Virus Vaccine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Inactivated Polio Virus Vaccine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Inactivated Polio Virus Vaccine Market Share by Region: 2022 VS 2029
Figure 14. Global Inactivated Polio Virus Vaccine Market Share by Players in 2022
Figure 15. Global Top Inactivated Polio Virus Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Virus Vaccine as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Inactivated Polio Virus Vaccine Revenue in 2022
Figure 17. North America Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Inactivated Polio Virus Vaccine Market Share by Type (2018-2029)
Figure 19. North America Inactivated Polio Virus Vaccine Market Share by Application (2018-2029)
Figure 20. North America Inactivated Polio Virus Vaccine Market Share by Country (2018-2029)
Figure 21. United States Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Inactivated Polio Virus Vaccine Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Inactivated Polio Virus Vaccine Market Share by Type (2018-2029)
Figure 25. Europe Inactivated Polio Virus Vaccine Market Share by Application (2018-2029)
Figure 26. Europe Inactivated Polio Virus Vaccine Market Share by Country (2018-2029)
Figure 27. Germany Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Inactivated Polio Virus Vaccine Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Inactivated Polio Virus Vaccine Market Share by Type (2018-2029)
Figure 35. China Inactivated Polio Virus Vaccine Market Share by Application (2018-2029)
Figure 36. Asia Inactivated Polio Virus Vaccine Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Inactivated Polio Virus Vaccine Market Share by Type (2018-2029)
Figure 38. Asia Inactivated Polio Virus Vaccine Market Share by Application (2018-2029)
Figure 39. Asia Inactivated Polio Virus Vaccine Market Share by Region (2018-2029)
Figure 40. Japan Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Inactivated Polio Virus Vaccine Market Share by Country (2018-2029)
Figure 50. Brazil Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Sanofi Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2018-2024)
Figure 57. GSK Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2018-2024)
Figure 58. Serum Institute (Bilthoven Biologicals) Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2018-2024)
Figure 59. IMBCA Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2018-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed